A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in Patients Undergoing Bronchoscopy

Trial Profile

A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in Patients Undergoing Bronchoscopy

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs Remimazolam (Primary) ; Midazolam
  • Indications Sedation
  • Focus Registrational; Therapeutic Use
  • Sponsors PAION
  • Most Recent Events

    • 28 Jul 2017 Status changed from recruiting to completed.
    • 28 Jun 2017 Primary endpoint of success of procedure has been met, according to a PAION media release.
    • 28 Jun 2017 Results published in a PAION Media Release
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top